Cutaneous vasculitis associated with didanosine

Pinto, Pedro Herranz; Fernández-Díaz, M.L.; Lucas, R. de; González-García, Juan; Casado, Mariano

doi:10.1016/s0140-6736(94)92111-3

Cited by 23 publications

(7 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Parotid gland lipomatosis has been associated with protease inhibitor use [63]. Cutaneous vasculitis has been associated with zidovudine and didanosine [64,65]. Hyperuricemia and gout have been associated with retronavir [66].…”

Section: Disorders As a Results Of Hiv Treatmentmentioning

confidence: 99%

Rheumatic manifestations of human immunodeficiency virus infection

Louthrenoo

2008

Current Opinion in Rheumatology

View full text Add to dashboard Cite

Various rheumatic syndromes have been recognized in HIV-infected patients, including noninfectious inflammatory arthropathies, musculoskeletal infections, vasculitides, lupus-like syndrome, polymyositis, diffuse infiltrative lymphocytosis syndrome, and other uncommon rheumatologic conditions. Highly active antiretroviral therapy has caused dramatic changes in natural history, long-term outcome, morbidity and mortality in these patients. This is associated with the introduction of immune reconstitution inflammatory syndrome, particularly sarcoidosis, increased incidence of septic complications, and declining incidence of diffuse infiltrative lymphocytosis syndrome.

show abstract

Section: Disorders As a Results Of Hiv Treatmentmentioning

confidence: 99%

Rheumatic manifestations of human immunodeficiency virus infection

Louthrenoo

2008

Current Opinion in Rheumatology

View full text Add to dashboard Cite

show abstract

“…41,42 Individual case reports have described StevenseJohnson syndrome, cutaneous vasculitis, and papuloerythroderma of Ofuji as probable reactions to didanosine, and the prescribing information notes postmarketing reports of alopecia and anaphylactoid reactions. [43][44][45][46] However, it is difficult to know the clinical relevance of these reports because they represent only single cases and most are in the setting of high-dose didanosine. Lipodystrophy has been associated with didanosine, although not as strongly as with stavudine and some of the PIs.…”

Section: Didanosinementioning

confidence: 99%

Cutaneous toxicities of antiretroviral therapy for HIV

Introcaso

Hines

Kovarik

2010

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…34 Didanosine A case of SJS associated with didanosine has been reported. 35 Didanosine has also been implicated in leukocytoclastic vasculitis 36 and Ofuji papuloerythroderma. 37 Large-scale clinical trials have reported morbilliform and maculopapular rashes in approximately 3% of didanosine recipients.…”

Section: Emtricitabinementioning

confidence: 99%

Adverse Cutaneous Reactions to Antimicrobials in Patients with Human Immunodeficiency Virus Infection

Miller¹,

Warshaw²

2007

Dermatitis

View full text Add to dashboard Cite

Adverse reactions to medication are significant contributors to morbidity and mortality in patients with human immunodeficiency virus (HIV) infection. Cutaneous events not only constitute a significant portion of these reactions, they may also herald developing systemic reactions such as hemato-, nephro-, and hepatotoxicity. The identification of cutaneous adverse reactions and drug culprits and the proper management of reactions are of paramount importance for these patients. This review focuses specifically on adverse cutaneous reactions to antimicrobials that are commonly used in the management of patients with HIV infection.

show abstract

Cutaneous vasculitis associated with didanosine

Cited by 23 publications

References 5 publications

Rheumatic manifestations of human immunodeficiency virus infection

Rheumatic manifestations of human immunodeficiency virus infection

Cutaneous toxicities of antiretroviral therapy for HIV

Adverse Cutaneous Reactions to Antimicrobials in Patients with Human Immunodeficiency Virus Infection

Contact Info

Product

Resources

About